This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The cost of reversing the effects of climate change -- restoring melted polar sea ice, for example -- quickly climbs nearly fourfold soon after a tipping point is crossed, according to new work. Much work has been done to explore the environmental costs tied to climate change. But this new study marks the first time researchers have quantified the costs of controlling tipping points before and after they unfold.
Positive results from a study of Winrevair could help the drugmaker achieve sales growth past top-seller Keytruda’s upcoming patent expirations this decade.
TUESDAY, Nov. 26, 2024 -- The “brain fog” of long COVID might be due to impaired lung function following a person’s infection, a new small-scale study says.Reduced gas exchange in the lungs – oxygen coming in, carbon dioxide going out -- appears to.
In the ever-evolving landscape of pharmaceutical research and development, drug repurposing has emerged as a promising strategy to bring new treatments to patients more quickly and cost-effectively. However, navigating the complex web of intellectual property rights and regulatory considerations in this field can be challenging.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
A tiny, four-fingered 'hand' folded from a single piece of DNA can pick up the virus that causes COVID-19 for highly sensitive rapid detection and can even block viral particles from entering cells to infect them, researchers report. Dubbed the NanoGripper, the nanorobotic hand also could be programmed to interact with other viruses or to recognize cell surface markers for targeted drug delivery, such as for cancer treatment.
The brain drug developer is letting go of around 41 of its 238 employees, in a move the company says will help “align resources” with its strategic priorities.
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
The brain drug developer is letting go of around 41 of its 238 employees, in a move the company says will help “align resources” with its strategic priorities.
THURSDAY, Nov. 28, 2024 -- Geoffrey Pointing says its hard to describe the distress of an asthma or COPD flare-up.“Honestly, when you're having a flare up, it's very difficult to tell anybody how you feel - you can hardly breathe,” Pointing, 77, of.
Understanding Unit Testing Unit testing is a crucial aspect of software development, especially in complex applications like Android apps. It involves testing individual units of code, such as methods or classes, in isolation. This ensures the correctness of each component, leading to a more robust and reliable application. Why Unit Testing in MVVM?
A striking new phenomenon is emerging: distinct regions are seeing repeated heat waves that are so extreme, they fall far beyond what any model of global warming can predict or explain. A new study provides the first worldwide map of such regions, which show up on every continent except Antarctica like giant, angry skin blotches.
Long-awaited results released Tuesday showed adding tiragolumab to Roche's immunotherapy Tecentriq did not extend survival in a closely followed Phase 3 study called SKYSCRAPER-01.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
THURSDAY, Nov. 28, 2024 -- People whose partners have HIV must remember to take antiretroviral pills every single day or risk infection themselves.But researchers have come up with a way to avoid that daily hassle – an injectable drug that patients.
Patient centricity has become a crucial aspect of the pharmaceutical industry, particularly in the development of generic drugs. This approach focuses on understanding and addressing the needs and preferences of patients to ensure that the medications they receive are safe, effective, and easy to use.
Recent results from a recent clinical trial indicate that a twice-yearly injection of Lenacapavir offers an overall 96% reduced risk of acquiring HIV. This makes Lenacapavir significantly more effective than the standard daily oral PrEP (pre-exposure prophylaxis).
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
WEDNESDAY, Nov. 27, 2024 -- Already the go-to drug of choice for millions with type 2 diabetes, metformin might also fight lung cancer if those patients have it as well, new research shows.Metformin appears to help boost the benefits of.
Last month, we welcomed Aidan Gomez, CEO and Co-founder of Cohere, for our Scale Up series. As a leader in AI, Aidan co-authored the influential " Attention is All You Need " paper during his time at Google and has since co-founded Cohere , the leading data security-focused enterprise AI company. With the explosion of advancements in AI and its growing impact on industries worldwide, including drug discovery, our team was eager to hear Aidan’s unique technical perspective on building and scaling
A new computer model can be used to detect and measure interior oceans on the ice covered moons of Uranus. The model works by analyzing orbital wobbles that would be visible from a passing spacecraft. The research gives engineers and scientists a slide-rule to help them design NASA's upcoming Uranus Orbiter and Probe mission.
The biotechnology company, which sees itself as "pretty conservative," recently put out an ambitious long-term revenue forecast for its schizophrenia and depression medicine Caplyta.
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
TUESDAY, Nov. 26, 2024 -- The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered by Medicare and Medicaid.However, the move would have to be approved.
As the journey toward realising the full potential of precision medicine continues, one question frequently arises among pharma executives and biotech founders: why is progress so slow? A significant part of the answer may lie in the limitations of current technology in handling complex, multi-modal data – data that is crucial for advancing drug discovery and identifying new targets.
Increasing physical activity levels could extend your life up to 11 more years according to new research using accelometry data. The study found that for the least active people in the population, a single one-hour walk could return a benefit of six additional hours of life.
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
MONDAY, Nov. 25, 2024 -- Women, especially those who had high blood pressure during pregnancy or entered menopause before age 45, are among those with a greater risk for stroke.They and other high-risk groups are the focus of new stroke prevention.
In the world of biopharmaceuticals, Dr Catherine Pickering stands out as a pioneering leader. As the CEO of iOnctura, an innovative oncology biopharmaceutical company she co-founded in 2017, Catherine has played a key role in advancing the development of highly targeted small molecules aimed at revolutionising cancer treatment. Her journey in drug R&D and business development has been marked by significant achievements, including leading groundbreaking efforts to treat neglected cancers and
Researchers have made a record-breaking astrophysical discovery while simultaneously uncovering a possible explanation for the rare and extreme astrophysical event known as long-period radio transients.
The setback likely removes one competitor to an emerging spinal muscular atrophy medicine from Scholar Rock, but sets the stage for a pair of readouts with implications for weight loss research.
MONDAY, Nov. 25, 2024 -- New research suggests that a thyroid medication often prescribed to older Americans may be linked to a common problem in old age -- bone loss. Levothyroxine is a synthetic hormone often prescribed to treat hypothyroidism.
Ladders to Cures (L2C) Accelerator By Maria Nemchuk November 25, 2024 Breadcrumb Home Ladders to Cures (L2C) Accelerator The Ladders to Cures (L2C) Accelerator aims to catalyze progress across the research ecosystem and accelerates advances leading to treatments and cures for patients with rare genetic diseases. We are a community of scientists, physicians, patient advocacy groups, AI/machine learning experts and biopharma veterans working together to gain new mechanistic insights and advance tr
A team has solved a mystery that has intrigued scientists for centuries: how does the squirting cucumber squirt? The findings were achieved through a combination of experiments, high-speed videography, image analysis, and advanced mathematical modelling.
Kronos is cutting 83% of its workforce, while Idorsia is considering eliminating as many as 270 jobs. Elsewhere, PTC disclosed negative Phase 2 results for its ALS drug candidate utreloxastat.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
345 
Let's personalize your content